SCHEMBL7256709

SCHEMBL7256709

COc1ccc(-c2cn(CCC3OCCO3)c3cc(OC)cc(OC)c3c2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.46
CYP3A4 P08684 6/20 0.46
KDM4E B2RXH2 4/20 0.46
HSD17B10 Q99714 4/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
EGFR P00533 3/20 0.41
MGAM O43451 3/20 0.41
SLC22A2 O15244 1/20 0.40
SLC22A1 O15245 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
MAPT P10636 5/20 0.40
MAPK1 P28482 2/20 0.40
ABCG2 Q9UNQ0 1/20 0.40
SMN1; SMN2 Q16637 5/20 0.38
TP53 P04637 3/20 0.38
HPGD P15428 3/20 0.38
CYP2D6 P10635 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7256736 0.84 CNR2 (0.40) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7536631 0.81 CASP3 (0.47) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7261259 0.81 EGFR (0.48) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7257604 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7261248 0.79 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7256749 0.79 ALDH1A1 (0.48) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7532023 0.79 EGFR (0.48) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7256772 0.78 ALDH1A1 (0.46) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7261275 0.78 ALDH1A1 (0.45) ALDH1A1CYP3A4KDM4EHSD17B10NPC1
SCHEMBL7260717 0.77 ALDH1A1 (0.48) ALDH1A1CYP3A4KDM4EHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6645983-B1 Heterocyclic imines such as 3-(4-methoxyphenyl)-1,4-dihydro-4 -quinolinone, used as anticarcinogenic agents having cytolysis efficiency; side effect reduction LABORATOIRE L. LAFON (FR) 2003-11-11 US disclosed
WO-2002022074-A2 USE OF 2- AND 4- QUINOLONES FOR INHIBITING INTIMAL NEO-PROLIFERATION LABORATOIRE L. LAFON (FR) 2002-03-21 WO disclosed